Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Lormeau

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Thrombosis and Haemostasis|January 23, 1992
The mode of action of CY216 and CY222 in plasmaS Béguin, S Wielders, J C Lormeau, et al.
Annales Pharmaceutiques Francaises|July 1, 1981
[Low molecular weight oligosaccharides active in plasma against factor Xa. II. New structural elements and antithrombotic activity (author's transl)]J Choay, J C Lormeau, M Petitou, et al.
Journal of Cellular Physiology|September 1, 1989
Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cellsT Bârzu, J C Lormeau, M Petitou, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Structural studies on a biologically active hexasaccharide obtained from heparinJ Choay, J C Lormeau, M Petitou, et al.
Thrombosis and Haemostasis|December 1, 1994
Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasmaF A Ofosu, J C Lormeau, S Craven, et al.
Annales Pharmaceutiques Francaises|July 1, 1976
[Purification and properties of plasminogens extracted from human placenta]J C Lormeau, J Choay, J Goulay, et al.
Thrombosis and Haemostasis|May 4, 1992
Pharmacodynamic properties of long lasting butyryl heparin derivatives in the rabbitS Saivin, C Caranobe, M Petitou, et al.
Biochemistry|October 6, 1987
Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin IIID H Atha, J C Lormeau, M Petitou, et al.
Biochemistry|November 5, 1985
Contribution of monosaccharide residues in heparin binding to antithrombin IIID H Atha, J C Lormeau, M Petitou, et al.
Thrombosis and Haemostasis|February 1, 1994
Low affinity heparin is an antithrombotic agentE Gray, S Cesmeli, J C Lormeau, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Thrombosis and Haemostasis|January 23, 1992
The mode of action of CY216 and CY222 in plasmaS Béguin, S Wielders, J C Lormeau, et al.
Annales Pharmaceutiques Francaises|July 1, 1981
[Low molecular weight oligosaccharides active in plasma against factor Xa. II. New structural elements and antithrombotic activity (author's transl)]J Choay, J C Lormeau, M Petitou, et al.
Journal of Cellular Physiology|September 1, 1989
Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cellsT Bârzu, J C Lormeau, M Petitou, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Structural studies on a biologically active hexasaccharide obtained from heparinJ Choay, J C Lormeau, M Petitou, et al.
Thrombosis and Haemostasis|December 1, 1994
Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasmaF A Ofosu, J C Lormeau, S Craven, et al.
Annales Pharmaceutiques Francaises|July 1, 1976
[Purification and properties of plasminogens extracted from human placenta]J C Lormeau, J Choay, J Goulay, et al.
Thrombosis and Haemostasis|May 4, 1992
Pharmacodynamic properties of long lasting butyryl heparin derivatives in the rabbitS Saivin, C Caranobe, M Petitou, et al.
Biochemistry|October 6, 1987
Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin IIID H Atha, J C Lormeau, M Petitou, et al.
Biochemistry|November 5, 1985
Contribution of monosaccharide residues in heparin binding to antithrombin IIID H Atha, J C Lormeau, M Petitou, et al.
Thrombosis and Haemostasis|February 1, 1994
Low affinity heparin is an antithrombotic agentE Gray, S Cesmeli, J C Lormeau, et al.
Pageof 7